News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.8d agobullish
Is Earnings Beat Altering The Investment Case For AbbVie Stock (ABBV)?24/7 Wall St.89d agobullish
Eli Lilly Beat Big and Raised Guidance. Wall Street Sees More Room to RunBarrons.com100d agobullish
AbbVie Bought Apogee to Strengthen Its Portfolio. Now It’s Cutting Earnings Guidance.Investor's Business Daily103d agobullish
Botox Maker Tops Buy Point, But Here Comes The Earnings ReportInvestor's Business Daily125d agobullish
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into EarningsSimply Wall St.179d agobullish
A Look At AbbVie (ABBV) Valuation After New Immunology Data And Upgraded 2026 Earnings Outlook